LifeStance adds three directors, grants RSUs
LifeStance Health Group, Inc. reported changes to its board of directors.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. reported changes to its board of directors. Jeffrey Rhodes resigned from the board and all committees effective immediately, and the company stated his resignation was not due to any disagreement with the company.
To fill board vacancies, the board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as directors. Mr. Justice and Ms. Goltermann were named Class II directors, serving until the 2029 annual meeting of stockholders, while Mr. Shabab was named a Class III director, serving until the 2027 meeting.
Mr. Justice joined the audit committee and the quality and compliance committee, Ms. Goltermann joined the compensation and nominating and governance committees, and Mr. Shabab joined the nomination and governance committee. Under the 2021 Equity Incentive Plan, Mr. Justice and Ms. Goltermann each received 35,492 restricted stock units, which vest under a time- and performance-based agreement, subject to their continued board service.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
restricted stock units financial
2021 Equity Incentive Plan financial
audit committee financial
compensation committee financial
Stockholder’s Agreement regulatory
emerging growth company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did LifeStance Health (LFST) announce on July 2, 2026?
Who joined the LifeStance Health (LFST) board and how long will they serve?
Which board committees will the new LifeStance Health (LFST) directors serve on?
What equity awards did new LifeStance Health (LFST) directors receive?
How was Safwan Shabab’s appointment to the LifeStance Health (LFST) board governed?
AI-generated analysis. How Rhea-AI works. Not financial advice.